Betel Nut and Arecoline: Past, Present, and Future Trends
Innovations in Digital Health, Diagnostics, and Biomarkers · 2022
DOI: 10.36401/iddb-22-05 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovations in Digital Health, Diagnostics, and Biomarkers, 2022. Verfasst von Zisis Kozlakidis und 2 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The areca nut, commonly known as betel nut, has been the subject of consistent scientific study over the past 5 decades. Betel nut is a natural compound chewed for its psychostimulating effects. Arecoline, the primary alkaloid of betel nut, is a muscarinic acetylcholine receptor agonist producing cholinergic effects on the parasympathetic nervous system and a psychoactive agent, contributing to the psycho-stimulating effects. Importantly the betel nut use is also associated with oral leucoplakia, submucous fibrosis, and squamous cell carcinoma. This narrative review explores the past, present, and future aspects of betel nut use, its historical applications, the development of biomarkers research, its health value concerns, and health economic impacts.
Zitieren
APA
Kozlakidis, Z., Cheong, I. H., & Wang, H. (2022). Betel Nut and Arecoline: Past, Present, and Future Trends. Innovations in Digital Health, Diagnostics, and Biomarkers. https://doi.org/10.36401/iddb-22-05
Vancouver
Kozlakidis Z, Cheong IH, Wang H. Betel Nut and Arecoline: Past, Present, and Future Trends. Innovations in Digital Health, Diagnostics, and Biomarkers. 2022. doi:10.36401/iddb-22-05
BibTeX
@article{Kozlakidis2022,
author = {Kozlakidis, Zisis and Cheong, Io Hong and Wang, Hui},
title = {Betel Nut and Arecoline: Past, Present, and Future Trends},
journal = {Innovations in Digital Health, Diagnostics, and Biomarkers},
year = {2022},
doi = {10.36401/iddb-22-05}
}
EUVIMED